Comparative serum proteomic analysis involving liver organ-specific metastasis-associated proteins of nasopharyngeal carcinoma

Experimental and Therapeutic Medicine

Volumn 3, Issue 6, 2012, Pages 1055-1061

  Pan, Changchuan ^a,b   Tao, Yalan ^a   Zhao, Ming ^a   Li, Wang ^a   Huang, Zilin ^a   Gao, Jing ^a   Wu, Yanhen ^c   Yu, Jingrui ^b   Wu, Peihong ^a   Xia, Yunfei ^a   Lu, Jin ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SICHUAN CANCER HOSPITAL   (China)

^c THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

Author keywords

Liver metastasis; Nasopharyngeal carcinoma; Organ specific metastasis; Proteomics

Indexed keywords

PLASMA PROTEIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER METASTASIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NASOPHARYNX CARCINOMA; PROTEIN MICROARRAY; PROTEOMICS; RETROSPECTIVE STUDY; VALIDATION PROCESS;

EID: 84859473726     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.526     Document Type: Article

References (22)

1. Husemann Y, Geigl JB, Schubert F, etal: Systemic spread is an early step in breast cancer. Cancer Cell 13: 58-68, 2008.
2. Chiang AC and Massague J: Molecular basis of metastasis. N Engl J Med 359: 2814-2823, 2008.
3. Kam MK, Teo PM, Chau RM, etal: Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60: 1440-1450, 2004.
4. Hui EP, Leung SF, Au JSK, etal: Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group-a study by the Hong Kong nasopharyngeal carcinoma study group. Cancer 101: 300-306, 2004.
5. Teo PM, Kwan WH, Lee WY, etal: Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 77: 2423-2431, 1996.
6. Wang CT, Cao KJ, Li Y, etal: Prognosis analysis of nasopharyngeal carcinoma patients with distant metastasis. Ai Zheng 26: 212-215, 2007.
7. Pan C, He N, Zhao M, etal: Subdividing the M1 stage of liver metastasis for nasopharyngeal carcinoma to better predict metastatic survival. Med Oncol 28: 1349-1355, 2011.
8. Huang CJ, Leung SW, Lian SL, etal: Patterns of distant metastases in nasopharyngeal carcinoma. Kaohsiung J Med Sci 12: 229-234, 1996.
9. Huang YJ, Xuan C, Zhang BB, etal: SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma. J Exp Clin Cancer Res 28: 85, 2009.
10. Chang KP, Wu CC, Chen HC, etal: Identification of candidate nasopharyngeal carcinoma serum biomarkers by cancer cell secretome and tissue transcriptome analysis: potential usage of cystatin A for predicting nodal stage and poor prognosis. Proteomics 10: 2644-2660, 2010.
11. Wu CC, Chien KY, Tsang NM, etal: Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 5: 3173-3182, 2005.
12. Liao Q, Zhao L, Chen X, etal: Serum proteome analysis for profiling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyngeal carcinoma. Clin Exp Metastasis 25: 465-476, 2008.
13. Cheng AJ, Chen LC, Chien KY, etal: Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem 51: 2236-2244, 2005.
14. Chang JT, Chen LC, Wei SY, etal: Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometry-plasma peptidomes from nasopharyngeal cancer patients for example. Clin Biochem 39: 1144-1151, 2006.
15. Fokas E, Engenhart-Cabillic R, Daniilidis K, etal: Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev 26: 705-715, 2007.
16. Cho WC: Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer 6: 1, 2007.
17. Hudler P, Gorsic M and Komel R: Proteomic strategies and challenges in tumor metastasis research. Clin Exp Metastasis 27: 441-451, 2010.
18. Liao CC, Mehta A, Ward NJ, etal: Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological study. World J Surg Oncol 8: 33, 2010.
19. Zheng GX, Wang CX, Qu X, etal: Establishment of serum protein pattern for screening colorectal cancer using SELDI-TOF-MS. Exp Oncol 28: 282-287, 2006.
20. Luque-Garcia JL, Martinez-Torrecuadrada JL, Epifano C, etal: Differential protein expression on the cell surface of colorectal cancer cells associated to tumor metastasis. Proteomics 10: 940-952, 2010.
21. Pang J, Liu WP, Liu XP, etal: Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. J Proteome Res 9: 216-226, 2010.
22. Pei H, Zhu H, Zeng S, etal: Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res 6: 2495-2501, 2007.